Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with an interstitial lung disease (a group of conditions that cause scarring or inflammation in the lungs)
Who may not be able to join:
- People who have emphysema or other lung diseases that cause airflow blockage (known as obstructive lung diseases)
- People who currently have active cancer
- People whose kidneys are functioning very poorly (with a filtration rate below 30 ml/min) or who are on dialysis
- People who have liver failure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201006591449
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MucinB5 rs (35705950) gene polymorphism; Leucocytes telomere length
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.